Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Total Debt Summary of Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)'s latest annual total debt in 2023 was 74.8 Million SEK , up 252.78% from previous year.
Devyser Diagnostics AB (publ)'s latest quarterly total debt in 2024 Q2 was 64.8 Million SEK , down -5.12% from previous quarter.
Devyser Diagnostics AB (publ) reported annual total debt of 21.2 Million SEK in 2022, up 63.57% from previous year.
Devyser Diagnostics AB (publ) reported annual total debt of 12.96 Million SEK in 2021, down -39.71% from previous year.
Devyser Diagnostics AB (publ) reported quarterly total debt of 64.8 Million SEK for 2024 Q2, down -5.12% from previous quarter.
Devyser Diagnostics AB (publ) reported quarterly total debt of 68.3 Million SEK for 2024 Q1, down -8.69% from previous quarter.

Annual Total Debt Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Total Debt of Devyser Diagnostics AB (publ) (2023 - 2018)

Year	Total Debt	Total Debt Growth
2023	74.8 Million SEK	252.78%
2022	21.2 Million SEK	63.57%
2021	12.96 Million SEK	-39.71%
2020	21.5 Million SEK	-9.93%
2019	23.86 Million SEK	145.57%
2018	9.72 Million SEK	0.0%

Year	Total Debt	Total Debt Growth
2024 Q3	13.7 Million SEK	-5.56%
2024 Q2	64.8 Million SEK	-5.12%
2024 Q1	68.3 Million SEK	-8.69%
2023 FY	74.8 Million SEK	252.78%
2023 Q4	74.8 Million SEK	0.94%
2023 Q3	74.1 Million SEK	1.09%
2023 Q2	73.3 Million SEK	264.68%
2023 Q1	20.1 Million SEK	-5.2%
2022 Q1	13.1 Million SEK	1.06%
2022 Q3	17.6 Million SEK	-3.3%
2022 Q2	18.2 Million SEK	38.93%
2022 Q4	21.2 Million SEK	20.47%
2021 Q4	12.96 Million SEK	0.0%

Peer Total Debt Comparison of Devyser Diagnostics AB (publ)

Name	Total Debt	Total Debt Difference
AroCell AB (publ)	- SEK	-Infinity%
Immunovia AB (publ)	4.28 Million SEK	-1645.217%
Prostatype Genomics AB (publ)	67 Thousand SEK	-111541.791%
SenzaGen AB	1.67 Million SEK	-4371.01%
Spermosens AB	9.51 Million SEK	-685.962%